| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Innoviva, Inc. (INVA) has 3 insiders with recent SEC Form 4 filings, including 4 buys and 6 sells. INVA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 162.3K | $3.65M | - | |
| CFO | 51.3K | $1.15M | - | |
| Other | 48.3K | $1.09M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 27, 2020 | Innoviva, Inc.55 | 10% Owner | Buy | 7,717,661 | $2.87 | $22,149,687.07 | +777.1% | |
| Feb 24, 2020 | Zhen Marianne | Chief Accounting Officer | Sell | 2,954 | $14.78 | $43,660.12 | -11.9% | |
| Feb 27, 2019 | Bickerstaff George72 | Director | Buy | 15,000 | $15.90 | $238,500.00 | +38.7% | |
| Feb 26, 2019 | Zhen Marianne | Chief Accounting Officer | Sell | 5,617 | $16.00 | $89,872.00 | -23.1% | |
| Feb 21, 2019 | Bickerstaff George72 | Director | Buy | 10,000 | $14.90 | $148,958.00 | +34.8% | |
| Feb 15, 2019 | Hulme Geoffrey | Interim Peo | Buy | 7,000 | $14.80 | $103,600.00 | New | |
| Aug 21, 2018 | Abercrombie George B68 | Sr. VP &Chief Comm. Officer | Sell | 8,000 | $14.11 | $112,840.00 | -2.7% | |
| Aug 21, 2018 | Witek Theodore J. Jr. | Sr. VP &Chief Scientific Off. | Sell | 8,504 | $14.12 | $120,079.88 | -3.3% | |
| May 21, 2018 | Desparbes Eric | SVP And CFO | Sell | 5,808 | $14.40 | $83,623.00 | -1.5% | |
| May 21, 2018 | Abercrombie George B68 | Sr. VP &Chief Comm. Officer | Sell | 8,000 | $14.40 | $115,202.40 | -2.6% |